liver cancer
Top Five Articles on 360Dx Last Week: Mursla Bio's Liver Cancer Test; Use of LDTs Under IVDR; More
Last week, readers were most interested in a story about Mursla's liver cancer test for detecting microRNA and protein targets within extracellular vesicles.
The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.
Tencent Invests $30M in Early Cancer Detection Firm Insighta
Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
The company recently published data on the MESA platform's ability to screen for colorectal cancer and is considering other testing opportunities.